SENSEX NIFTY

Wockhardt Pharma

Jan 15, 2016 at 12:58 | Source: CNBC-TV18
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Vivimed Labs, Suzlon Energy, Aban Offshore, Marksans Pharma, Prakash Industries, Infosys, IndiGo, Cyient, Wockhardt & Strides Shasun.
Jan 02, 2016 at 10:34 | Source: CNBC-TV18
Aashish Tater of FortuneWizard.com feels that JB Chemicals may touch Rs 450.
Jan 01, 2016 at 20:49 | Source: CNBC-TV18
The reforms carried out by the government are going to result in an earnings gain for a lot of companies and one will have to dig deeper into themes that will likely benefit from the change, says Dipen Sheth of HDFC Securities.
Dec 31, 2015 at 11:44 | Source: CNBC-TV18
According to Sudarshan Sukhani of s2analytics.com, the correction in pharmaceutical stocks would be an opportunity.
Dec 31, 2015 at 08:58 | Source: PTI
Besides, Container Corporation and Torrent Pharma would also be the part of the derivative segment. Futures and options contracts on these four additional securities would be available for trading with effect from January 1, NSE said in a circular.
Dec 29, 2015 at 11:44 | Source: CNBC-TV18
Basant Maheshwari, Founder of The Equity Desk And Author of The Thoughtful Investor is of the view that one may prefer pharma stocks.
Dec 29, 2015 at 11:05 | Source: CNBC-TV18
Basant Maheshwari, Founder- Equity Desk says one should invest into midcap pharma stocks that cater to the US market as they have strict regulations.
Dec 21, 2015 at 10:20 | Source: PTI
On the annual Industrial R&D Investment Scoreboard for 2015, prepared by European Commission, Volkswagen is followed by Samsung, Microsoft, Intel and Novartis in the top-five.
Dec 18, 2015 at 08:43 | Source: CNBC-TV18
Manas Jaiswal of manasjaiswal.com recommends buying Firstsource Solutions with a target of Rs 47.50 and Indian Hotels with a target of Rs 120.
Dec 14, 2015 at 15:24 | Source: CNBC-TV18
Dipan Mehta, Member at BSE & NSE is of the view that one may prefer pharmaceutical stocks.
Messages on Wockhardt Pharma »

yksaraswat

Gold Member

331 Followers

Nectar Life  

Result on valentines day 14 feb. with wockhardt pharma.We all hopes good turn around story on the board.........yogesh

10.25 AM Feb 8th 2013

Reach4Stars

Silver Member

34 Followers

Marksans Pharma  

Within Pharma stocks, 2013 will belong to Marksans Pharma. 2012 was year of Wockhardt Pharma. Turnaround story for Marksans very similar to Wockhardt. We all saw Wockhardt moving from Rs 100 to Rs Rs 1500 . Story in Marksans will be even better. Just buy buy.... use every dip to accumulate. First

11.57 AM Dec 14th 2012

RAJ BHATIA

Platinum Member

368 Followers

Aurobindo Pharm  

IF U HAVE ENTERED IN WOCKHARDT PHARMA AT LOVER LEVELS U SHOULD BOOK PROFIT,BUT IN AUROBINDO AND DISHMAN I THINK LOT OF UP MOVE IS STILL PENDING.NOW IT IS UP TO U.

1.23 PM Nov 20th 2012

drrajc

New Member

0 Follower

Dabur India  

sir what is your view on Wockhardt pharma,Dabur and Hexaware?

12.52 PM Oct 13th 2012

drrajc

New Member

0 Follower

Hexaware Tech  

sir what is your view on Wockhardt pharma,Dabur and Hexaware?

12.52 PM Oct 13th 2012

drrajc

New Member

0 Follower

Wockhardt  

sir what is your view on Wockhardt pharma,Dabur and Hexaware?

12.50 PM Oct 13th 2012

meet1234

Gold Member

20 Followers

Wockhardt  

WOCKHARDT PHARMA SELL THIS LEVEL 1350 SELL AND REENTRY AFTER ONE MONTH 975-1000 RS AGAIN THIS LEVEL SELL SELLSELL.......................

11.22 PM Oct 11th 2012

LOLheehee

Gold Member

14 Followers

Kingfisher Air  

Sell half at loss...Invest that in Wockhardt pharma.. which is due to rocket up within a month...

1.10 PM Oct 3rd 2012

INVESTOR IDEA

Platinum Member

18 Followers

Orchid Chemical  

LOOK AT PHARMA SHARES WOckhardt pharma it was in losses and now at from 220 to 1400 levels

11.03 AM Sep 14th 2012

INVESTOR IDEA

Platinum Member

18 Followers

Orchid Chemical  

it may move up like wockhardt pharma wait and watch

1.20 PM Sep 3rd 2012

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.